Research ArticleANTIBODIES

Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes

See allHide authors and affiliations

Science Immunology  22 Feb 2019:
Vol. 4, Issue 32, eaav5062
DOI: 10.1126/sciimmunol.aav5062

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article